Arnold & Porter

Primarily centred from the East Coast but active on mandates throughout the country, Arnold & Porter capably combines regulatory, litigation and scientific knowledge for an impressive roster of leading pharmaceutical and medical device companies on their highest-profile product liability matters. Indeed, it is this ability to provide a full suite of services, including in relation to government investigations, that ensures that the firm is front and centre in the minds of many clients in the space when looking for a firm to take a leadership role on potentially brand-threatening aggregated proceedings. Under the guidance of New York-based Anand Agneshwar , the firm has garnered a number of notable victories for Sanofi in the sprawling MDL relating to their over-the-counter heartburn medication Zantac, including securing crucial Daubert judgments which effectively eliminated many thousands of claims. Head of the firm’s New York office, Arthur Brown  also regularly takes key leadership roles, in so doing helping to shape the strategy and work up cases ahead of trials; he continues to lead the firm’s role as national counsel to AstraZeneca in the proton pump inhibitor mass tort. Washington DC-based Paige Sharpe  is adept at defending pharmaceutical companies in both civil and governmental actions/investigations, bringing core litigation skills to bear at trial and appellate level, as well as advising on regulatory issues as well as in the context of risk management strategies. Agneshwar co-heads the overarching product liability litigation group alongside Washington DC-based Daphne O’Connor.